Venture In The South

E150: The 150th Anniversary Show

Venture In The South Season 3 Episode 150

E150: David opens with the weekly venture update then joins Paul to discuss significant portfolio events in 2024 including: 

  • Zylo Therapeutics
  • Aticus Pharma
  • Yuva Bio
  • Case Status
  • RoundlyX
  • luminelle
  • Altis Bio
  • Iconic

We then pose some questions for listeners about potential future show topics. (recorded 11.27.24)

Follow David and Paul:

https://x.com/DGRollingSouth

https://x.com/PalmettoAngel

Connect On LinkedIn:

https://www.linkedin.com/in/davidgrisell/

https://www.linkedin.com/in/paulclarkprivateequity/


We invite your feedback and suggestions at www.ventureinthesouth.com or email david@ventureinthesouth.com. Learn more about RollingSouth at rollingsouth.vc or email david@rollingsouth.vc.

People on this episode